Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Biomedicines · 2026 · PMC13024023 · PMID 41898189

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Our results showed a decreasing trend for IL-6 expression in asthma and EGPA subgroups, which is consistent with the mepolizumab modulatory effect on inflammation.

also in 29,529 other papers

a favorable trendno p-value reported

FeNO levels showed a favorable trend.

also in 993 other papers

a positive trendno p-value reported

Moreover, in the EGPA group, the correlation analysis between clinical scores and cytokines levels, at the baseline, showed a positive trend between eosinophils and IL-5.

also in 6,779 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.